| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 12/24/2008 | CN100445266C MCH antagonists and their use in treatment of obesity |
| 12/24/2008 | CN100444849C New use of tribulus terrestris extraction |
| 12/24/2008 | CN100444840C Method for reducing amyloid deposition, amyloid neurotoxicity and microgliosis |
| 12/24/2008 | CN100444839C Treatment of chemokine mediated diseases |
| 12/24/2008 | CN100444830C Multiparticulate modified release composition |
| 12/24/2008 | CA2698172A1 Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties |
| 12/24/2008 | CA2692249A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient |
| 12/24/2008 | CA2692248A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
| 12/24/2008 | CA2692039A1 Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating crf receptor signaling |
| 12/24/2008 | CA2691648A1 Cinnoline compounds for use in the treatment of schizophrenia |
| 12/24/2008 | CA2691223A1 6-(pyrrolopyridinyl) pyrimidin-2-ylamine derivatives and the use thereof for the treatment of cancer and aids |
| 12/24/2008 | CA2691208A1 Combination therapy for depression |
| 12/24/2008 | CA2691071A1 Neurosteroid compounds |
| 12/24/2008 | CA2690945A1 Composition for transdermal or transmucosal administration |
| 12/24/2008 | CA2690746A1 Compounds for treatment |
| 12/24/2008 | CA2690435A1 Humanized antibodies to amyloid beta |
| 12/24/2008 | CA2690434A1 Monoclonal anti beta amyloid antibody |
| 12/24/2008 | CA2690382A1 Antibody formulations |
| 12/24/2008 | CA2690249A1 Spiro [piperidine-4,4'-thieno[3,2-c]pyran] derivatives and related compounds as inhibitors of the sigma receptor for the treatment of psychosis |
| 12/24/2008 | CA2690079A1 Sulfonyl-quinoline derivatives |
| 12/24/2008 | CA2689208A1 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators |
| 12/24/2008 | CA2687258A1 Arylamide pyrimidone derivatives |
| 12/24/2008 | CA2687255A1 Heteroarylamide pyrimidone derivatives |
| 12/24/2008 | CA2687156A1 Arylamide pyrimidone compounds |
| 12/24/2008 | CA2687151A1 Heteroarylamide pyrimidone compounds |
| 12/23/2008 | US7468443 central nervous system disorders; regenerating nervous systems |
| 12/23/2008 | US7468389 Cyclopropane carboxylic acid for treatment of nervous system disorders and for slowing metabolism |
| 12/23/2008 | US7468377 Imidazopyridine-derivatives as inductible no-synthase inhibitors |
| 12/23/2008 | US7468368 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 12/23/2008 | US7468367 depression; anxiety; addictions; obsessive compulsive disorder; affective neurosis/disorder; depressive neurosis/disorder, anxiety neurosis; dysthymic disorder; behaviour disorder; mood disorder; sexual dysfunction; psychosexual dysfunction; sex disorder, sexual disorder; schizophrenia; manic depression; |
| 12/23/2008 | US7468365 Lactam compound |
| 12/23/2008 | US7468361 For therapy of skin conditions selected from the group consisting of dermatitis, eczema, keratosis, lack of skin firmness, wrinkles, lack of dermal hydration and insufficient sebum secretion |
| 12/23/2008 | US7468359 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 12/23/2008 | US7468276 Bloodless mammalian placenta for use in generating multipotent stem cells |
| 12/23/2008 | US7468270 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 12/23/2008 | US7468189 Injection of botulinum toxin types A, B, C1, D, E, F or G as analgesic for diabetes- or cancer-associated pain not associated with headache or muscle spasm |
| 12/23/2008 | US7468179 Aerosol for delivery of naltrexone, buprenorphine, nalbuphine, naloxone, butorphanol, hydromorphone, oxycodone, methadone, remifentanil, sufentanil, or fentanyl by vaporizing the drug, which is coated on support and condensing to form aerosol with mass median aerodynamic diameter of less than 5 microns |
| 12/23/2008 | CA2560580C Imidazole compounds for inhibition of a.beta.-peptide production and for modulation of the notch signaling pathway |
| 12/23/2008 | CA2442557C Dihydro-benzo¬b|¬1,4|diazepin-2-one derivatives as mglur2 antagonists ii |
| 12/23/2008 | CA2424664C Novel non-imidazole compounds |
| 12/23/2008 | CA2372339C Pharmaceutical product comprising the active substance diamorphine, and its use in a process for treating opiate addiction |
| 12/23/2008 | CA2334520C Treatment of immune diseases |
| 12/23/2008 | CA2331685C Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 12/23/2008 | CA2326339C Use of dexmedetomidine for icu sedation |
| 12/23/2008 | CA2319810C Propofol composition containing sulfite |
| 12/23/2008 | CA2305799C Composition for the treatment of nicotine addiction containing a nicotine receptor antagonist and an anti-depressant or anti-anxiety drug |
| 12/23/2008 | CA2245267C Crystal form of n-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 12/23/2008 | CA2139515C Method for preventing zoster or alleviating varicella related post-herpetic neuralgia |
| 12/18/2008 | WO2008154579A1 Allopregnanolone in a method for enhancing neurological function (alzheimer disease) |
| 12/18/2008 | WO2008154500A1 Compositions and methods for polymer-caged liposomes |
| 12/18/2008 | WO2008153958A2 Crystalline forms of (r)-1-{2-[4'- (3-methoxy-propane-1- sulfonyl)-biphenyl-4-yl]-ethyl}-2-methyl-pyrrolidine, and compositions, and methods related thereto |
| 12/18/2008 | WO2008153929A1 Igf for the treatment of rett syndrome and synaptic disorders |
| 12/18/2008 | WO2008153902A2 Urotensin ii receptor antagonists |
| 12/18/2008 | WO2008153793A2 Gamma secretase modulators |
| 12/18/2008 | WO2008153792A2 Gamma secretase modulators |
| 12/18/2008 | WO2008153722A1 Post-translational regulation of catalytic activities of cytochrome p450 46a1 and uses thereof |
| 12/18/2008 | WO2008153611A2 Sustained delivery formulations of risperidone compounds |
| 12/18/2008 | WO2008153573A1 4-phenylpiperazine derivatives with functionalized linkers as dopamine d3 receptor selective ligands and methods of use |
| 12/18/2008 | WO2008153072A1 Gene sensitive to bone/joint disease and use thereof |
| 12/18/2008 | WO2008153027A1 Pyrroloquinoline derivative and use thereof |
| 12/18/2008 | WO2008152729A1 Jelly-like pharmaceutical composition containing risperidone |
| 12/18/2008 | WO2008152420A1 New compounds 892 |
| 12/18/2008 | WO2008152226A2 Homogeneous and stable composition rich in oleaginous substances based on a milk product, method for the preparation thereof and uses thereof |
| 12/18/2008 | WO2008152090A1 Novel compound |
| 12/18/2008 | WO2008152089A1 Novel compounds |
| 12/18/2008 | WO2008152086A2 4,5-dihydro-(1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators |
| 12/18/2008 | WO2008152068A2 [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases |
| 12/18/2008 | WO2008151969A1 Piperazine and [1,4] diazepan derivatives as nk antagonists |
| 12/18/2008 | WO2008151841A2 Treatment for alzheimer' s disease |
| 12/18/2008 | WO2008151833A2 Compounds for the modulation of huntingtin aggregation, methods and means for identifying such compounds |
| 12/18/2008 | WO2008151803A2 New polymorphisms in abcb1 associated with a lack of clinical response to medicaments |
| 12/18/2008 | WO2008151637A2 Neuroplastin derived peptides |
| 12/18/2008 | WO2008151437A1 Heme-oxygenase inhibitors and use of the same in the treatment of cancer and diseases of the central nervous system |
| 12/18/2008 | WO2008100457A3 Functionally selective alpha2c adrenoreceptor agonists |
| 12/18/2008 | WO2008089201A3 Heterocyclic-substituted piperidine as orl-1 ligands |
| 12/18/2008 | WO2008067390A3 Metabolites of 5-fluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl} quinoline and methods of preparation and uses thereof |
| 12/18/2008 | WO2008064244A3 Phosphoinositide modulation for the treatment of neurodegenerative diseases |
| 12/18/2008 | WO2008053356A3 Immediate release oxymorphone compositions and methods of using same |
| 12/18/2008 | WO2008033764A3 Quinazolinone and isoquinolinone acetamide derivatives |
| 12/18/2008 | WO2008031888A3 Condensed pyrimidinones active on glutamatergic receptors |
| 12/18/2008 | US20080312417 Ucp5 |
| 12/18/2008 | US20080312339 Fluorine-substituted alkyl phenol compounds and their uses |
| 12/18/2008 | US20080312338 Formulation |
| 12/18/2008 | US20080312332 G Protein-Coupled Receptor Antagonist and Its Use for Preventing and Treating Alzheimer's Disease |
| 12/18/2008 | US20080312326 Method for the Prevention and/or Treatment of Neurodegenerative Diseases Characterized by Administering and Ep1 Receptor Antagonist |
| 12/18/2008 | US20080312318 Deuterium-enriched escitalopram |
| 12/18/2008 | US20080312311 Crystalline forms of 3-(2R-tetrahydrofuryl-methyl)-2-thioxanthine |
| 12/18/2008 | US20080312303 Imidazole Derivatives and Their Use for Modulating the Gabaa Receptor Complex |
| 12/18/2008 | US20080312301 Substituted N-Benzo[D]Isoxazol-3-Yl-Amine Compounds as Inhibitors of Mglur5, Serotonin (5-Ht) and Noradrenaline Receptors, and Uses Thereof |
| 12/18/2008 | US20080312294 (4 beta S,7R,8 alpha R)-4 beta -benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-4 beta ,5,6,7,8,8 alpha ,9,10-octahydrophenanthrene-2-carboxamide; glucocorticoid receptor modulators; antiinflammatory agents; Alzheimer's disease; side effect reduction |
| 12/18/2008 | US20080312286 Indanone Potentiators of Metabotropic Glutamate Receptors |
| 12/18/2008 | US20080312284 3-(2-cyanophenyl)-5-(2-pyridyl)-1-phenyl-1,2-dihydropyridine-2-one; antagonistic action against AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor and/or inhibitory action against kainate receptor prophylactic agent for neurodegenerative diseases |
| 12/18/2008 | US20080312276 4,5 Dihydro-(1H)-Pyrazole Derivatives as Cannabinoid CB1 Receptor Modulators |
| 12/18/2008 | US20080312274 Quinoline Derivatives as Neurokinin Receptor Antagonists |
| 12/18/2008 | US20080312271 Azabenzimidazolyl compounds |
| 12/18/2008 | US20080312269 Therapeutic Agents |
| 12/18/2008 | US20080312268 Substituted tricyclic piperidone compounds |
| 12/18/2008 | US20080312266 Steroidal Compounds For Inhibiting Steroid Sulphatase |
| 12/18/2008 | US20080312262 Such as 2-(methylamino)-2-oxoethyl {2-[(4-chlorophenyl)oxy]ethyl}carbamate; sleep disorders |
| 12/18/2008 | US20080312254 Process for the Preparation of Ziprasidone |